Atlas Trials

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Clinical trial NCT06472479 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06472479
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple Myeloma
Start date
2024-07-01
Primary completion
2028-08-22
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.